Cargando…

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults

The contribution of nonalcoholic fatty liver disease (NAFLD) to all-cause and cardiovascular mortality remains controversial. Sarcopenia, a measure of muscle mass, strength and function, may identify which persons are most at risk for adverse effects of NAFLD. We aimed to test the hypothesis that sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xingxing, Liu, Zhelong, Chen, Fuqiong, Du, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329219/ https://www.ncbi.nlm.nih.gov/pubmed/34341404 http://dx.doi.org/10.1038/s41598-021-95108-1

Ejemplares similares

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2019)

Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
por: Zheng, Jia-Rui, et al.
Publicado: (2023)

Interaction between sarcopenia and nonalcoholic fatty liver disease
por: Joo, Sae Kyung, et al.
Publicado: (2023)

Besides Sarcopenia, Pre-Sarcopenia Also Predicts All-Cause Mortality in Older Chileans
por: Lera, Lydia, et al.
Publicado: (2021)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
por: Du, Tingting, et al.
Publicado: (2015)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2018)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
por: Chung, Goh Eun, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020)

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
por: Noh, Junghyun
Publicado: (2020)

Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease
por: Chen, Yuxiong, et al.
Publicado: (2022)

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus
por: Zhang, Xingxing, et al.
Publicado: (2022)

Bilateral breast myxedema caused by Graves’ disease and responsive to multipoint subcutaneous injection of long-acting glucocorticoid: Case report
por: Du, Tingting, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease, circulating ketone bodies and all‐cause mortality in a general population‐based cohort
por: Post, Adrian, et al.
Publicado: (2021)

The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease
por: Zhao, Enfa, et al.
Publicado: (2023)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
por: Konyn, Peter, et al.
Publicado: (2023)

Renal hyperfiltration, fatty liver index, and the hazards of all-cause and cardiovascular mortality in Finnish men
por: Ould Setti, Mounir, et al.
Publicado: (2020)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
por: Bisaccia, Giandomenico, et al.
Publicado: (2020)

Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey
por: Yue, Wenzhu, et al.
Publicado: (2019)

Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2023)

Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
por: Golabi, Pegah, et al.
Publicado: (2019)

Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

Longitudinal association of edentulism with cognitive impairment, sarcopenia and all-cause mortality among older Chinese adults
por: Li, Yang, et al.
Publicado: (2023)

Respiratory sarcopenia is a predictor of all‐cause mortality in community‐dwelling older adults—The Otassha Study
por: Kera, Takeshi, et al.
Publicado: (2023)

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
por: Kumar, Mavidi Sunil, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
por: Chiriac, Stefan, et al.
Publicado: (2021)

High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia
por: Han, Eugene, et al.
Publicado: (2023)

Diabetes modifies the association of prehypertension with cardiovascular disease and all‐cause mortality
por: Ren, Yanlong, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
por: Alferink, Louise Johanna Maria, et al.
Publicado: (2019)

Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study
por: Zhao, Ze-Hua, et al.
Publicado: (2022)

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
por: Arvind, Ashwini, et al.
Publicado: (2021)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
por: Barbarroja, Nuria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l44sja3e6r83gam3bcneshubn2